granisetron has been researched along with Constipation in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 10 (58.82) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 5 (29.41) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iwata, N; Kishi, T; Matsuda, Y; Mukai, T | 1 |
| Iwase, O; Nakajima, A; Nakamura, H; Okuyama, K; Takayanagi, R; Yamada, Y; Yokoyama, H; Yoshimoto, K | 1 |
| Eguchi, K; Hoshi, E; Katsumata, N; Kawahara, M; Takagi, M; Takahashi, T | 1 |
| Hori, K; Kawakami, J; Motohashi, S; Ohnishi, K; Ono, T | 1 |
| Goto, T; Ishibashi, M; Okamura, S; Tanimoto, K | 1 |
| Wilkes, G | 1 |
| Sanger, GJ; Wardle, KA | 1 |
| Fitts, D; Gralla, RJ; Grunberg, SM; Kaplan, HG; Navari, RM; Palmer, R | 1 |
| Cedar, E; Cunningham, J; Goedhals, L; Heron, JF; Jordaan, JP | 1 |
| Ang, PT; Khoo, KS; Tan, EH | 1 |
| Dott, CS; Joss, RA | 1 |
| de Wet, M; Falkson, G; Rapoport, BL | 1 |
| Carmichael, J; Cupissol, D; Keizer, HJ; Milliez, J; Scheidel, P; Schindler, AE | 1 |
| Antimi, M; Azevedo, MC; Balmes, H; Contu, A; García-Girón, C; Kleisbauer, JP; Luque, A; Massuti-Sureda, B; Pellier, P | 1 |
| Bingham, A; Houston, SA; Lindley, CM; McCune, JS; Oertel, MD; Pfeifer, D; Sawyer, WT | 1 |
| Allen, A; Arnold, BD; Link, C; Pierce, DM; Tasker, TC; Upward, JW | 1 |
| Tabona, MV | 1 |
1 review(s) available for granisetron and Constipation
| Article | Year |
|---|---|
Selective serotonin 3 receptor antagonist treatment for schizophrenia: meta-analysis and systematic review.
Topics: Antipsychotic Agents; Constipation; Double-Blind Method; Drug Therapy, Combination; Granisetron; Haloperidol; Humans; Indoles; Nausea; Ondansetron; Randomized Controlled Trials as Topic; Receptors, Serotonin, 5-HT3; Risperidone; Schizophrenia; Serotonin 5-HT3 Receptor Antagonists; Severity of Illness Index; Symptom Assessment; Treatment Outcome; Tropisetron; Vomiting | 2014 |
7 trial(s) available for granisetron and Constipation
| Article | Year |
|---|---|
Multicenter, phase II, placebo-controlled, double-blind, randomized study of aprepitant in Japanese patients receiving high-dose cisplatin.
Topics: Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Aprepitant; Asian People; Cisplatin; Constipation; Dexamethasone; Double-Blind Method; Drug Administration Schedule; Female; Granisetron; Hiccup; Humans; Japan; Male; Middle Aged; Morpholines; Nausea; Neoplasms; Placebos; Treatment Outcome | 2010 |
Efficacy and safety of granisetron, a selective 5-hydroxytryptamine-3 receptor antagonist, in the prevention of nausea and vomiting induced by high-dose cisplatin.
Topics: Adolescent; Adult; Aged; Cisplatin; Constipation; Diarrhea; Double-Blind Method; Female; Granisetron; Headache; Humans; Infusions, Intravenous; Male; Middle Aged; Nausea; Neoplasms; Serotonin; United States; Vomiting | 1994 |
Oral granisetron alone and in combination with dexamethasone: a double-blind randomized comparison against high-dose metoclopramide plus dexamethasone in prevention of cisplatin-induced emesis. The Granisetron Study Group.
Topics: Administration, Oral; Adult; Aged; Chi-Square Distribution; Cisplatin; Constipation; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; Europe; Female; Granisetron; Headache; Humans; Male; Metoclopramide; Middle Aged; Nausea; Prognosis; South Africa; Vomiting | 1994 |
Control of emesis by intravenous granisetron in breast cancer patients treated with 5-FU, epirubicin and cyclophosphamide.
Topics: Administration, Oral; Adult; Aged; Breast Neoplasms; Constipation; Cyclophosphamide; Epirubicin; Female; Fluorouracil; Flushing; Granisetron; Headache; Humans; Injections, Intravenous; Metoclopramide; Middle Aged; Nausea; Tablets; Vomiting | 1994 |
Use of granisetron in patients refractory to previous treatment with antiemetics.
Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Child; Cisplatin; Constipation; Drug Resistance; Female; Granisetron; Headache; Humans; Male; Middle Aged; Nausea; Serotonin Antagonists; Treatment Outcome; Vomiting | 1998 |
Granisetron plus methylprednisolone for the control of high-dose cisplatin-induced emesis.
Topics: Abdominal Pain; Adolescent; Adult; Aged; Antiemetics; Antineoplastic Agents; Blood Urea Nitrogen; Cisplatin; Constipation; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Granisetron; Headache; Humans; Leukopenia; Male; Methylprednisolone; Middle Aged; Nitrogen; Treatment Outcome; Vomiting | 1998 |
The clinical pharmacology of granisetron (BRL 43694), a novel specific 5-HT3 antagonist.
Topics: Blood Pressure; Constipation; Dose-Response Relationship, Drug; Electrocardiography; Granisetron; Half-Life; Humans; Indazoles; Psychomotor Performance; Pulse; Receptors, Serotonin; Serotonin Antagonists | 1990 |
9 other study(ies) available for granisetron and Constipation
| Article | Year |
|---|---|
Theoretical evaluation of antiemetic effects of 5-HT3 receptor antagonists for prevention of vomiting induced by cisplatin.
Topics: Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Cisplatin; Constipation; Creatinine; Granisetron; Humans; Hydroxyindoleacetic Acid; Intestine, Small; Isoquinolines; Models, Biological; Nausea; Oxazines; Palonosetron; Quinuclidines; Receptors, Serotonin, 5-HT3; Serotonin; Serotonin 5-HT3 Receptor Antagonists; Vomiting | 2015 |
[Comparison of 1 mg/body and 3 mg/body of intravenous granisetron for the prevention of chemotherapy-induced nausea and vomiting and adverse events in hematological malignancy patients].
Topics: Adult; Aged; Aged, 80 and over; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Constipation; Dose-Response Relationship, Drug; Female; Granisetron; Hematologic Neoplasms; Humans; Infusions, Intravenous; Male; Middle Aged; Nausea; Retrospective Studies; Serotonin Antagonists; Vomiting | 2012 |
[Efficacy of granisetron for preventing chemotherapy-induced nausea and vomiting in patients with acute myelogenous leukemia treated with a combination of anthracycline and cytarabine].
Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Constipation; Cytarabine; Female; Granisetron; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Nausea; Retrospective Studies; Vomiting; Young Adult | 2012 |
Antiemetic agents.
Topics: Administration, Oral; Anorexia; Antiemetics; Antineoplastic Agents; Aprepitant; Asthenia; Constipation; Diarrhea; Drug Interactions; Dyspepsia; Fatigue; Fever; Granisetron; Headache; Hiccup; Humans; Indoles; Injections, Intravenous; Isoquinolines; Morpholines; Nausea; Neoplasms; Ondansetron; Palonosetron; Quinolizines; Quinuclidines; Vomiting | 2007 |
Constipation evoked by 5-HT3-receptor antagonism: evidence for heterogeneous efficacy among different antagonists in guinea-pigs.
Topics: Animals; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Clonidine; Colon; Constipation; Defecation; Drug Interactions; Granisetron; Guinea Pigs; In Vitro Techniques; Indoles; Injections, Intraperitoneal; Male; Morphine; Muscle Contraction; Muscle, Smooth; Naloxone; Serotonin Antagonists; Tropisetron | 1994 |
Clinical studies with granisetron, a new 5-HT3 receptor antagonist for the treatment of cancer chemotherapy-induced emesis. The Granisetron Study Group.
Topics: Adult; Aged; Antiemetics; Antineoplastic Agents; Constipation; Dose-Response Relationship, Drug; Female; Granisetron; Headache; Humans; Indazoles; Male; Middle Aged; Serotonin Antagonists; Vomiting | 1993 |
Repeated use of granisetron in patients receiving cytostatic agents.
Topics: Adult; Age Factors; Aged; Antiemetics; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Constipation; Female; Granisetron; Headache; Humans; Indazoles; Infusions, Intravenous; Male; Middle Aged; Nausea; Remission Induction; Serotonin Antagonists; Vomiting | 1993 |
Evaluation of outcomes in converting from intravenous ondansetron to oral granisetron: an observational study.
Topics: Administration, Oral; Adolescent; Adult; Antiemetics; Child; Constipation; Diarrhea; Drug Utilization Review; Drug-Related Side Effects and Adverse Reactions; Female; Granisetron; Guideline Adherence; Headache; Humans; Injections, Intravenous; Male; Middle Aged; Ondansetron; Organizational Policy; Treatment Outcome | 2001 |
An overview on the use of granisetron in the treatment of emesis associated with cytostatic chemotherapy.
Topics: Antineoplastic Agents; Constipation; Granisetron; Headache; Humans; Indazoles; Serotonin Antagonists; Time Factors; Vomiting | 1990 |